TRILUMA® (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) Cream is indicated for the shortterm (up to 8 weeks) treatment of moderate to severe melasma of the face in the presence of measures for sun avoidance, including the use of sunscreens.

For more information on Fluocinolone Acetonide, click here.

For more information on Tretinoin , click here.

To read more about Epiquin Micro, please click here.